Deborah Vogt

7PUBLICATIONS
12CO-AUTHORS
Medical microbiology not elsewhere classifiedHuman impacts of climate change and human adaptationPsychological methodology, design and analysisPharmaceutical delivery technologiesMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 27, 2026
Misnomers in Dermatology and Other Medical Specialties-How to Deal with Science Fiction?

|Apr 11, 2026
Copeptin kinetics in healthy aging.

Sven Lustenberger, Friederike Riehle, Leyla Blattmann

|Sep 18, 2023
Sensitivity, specificity, and diagnostic accuracy of WHO 2013 criteria for diagnosis of gestational diabetes mellitus in low risk early pregnancies: international, prospective, multicentre cohort study.

Evelyn A Huhn, Christian S Göbl, Thorsten Fischer

|Nov 17, 2022
Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.

Julie Refardt, Cornelia Imber, Rianne Nobbenhuis

|Aug 20, 2021
Can treatment response to SGLT2-inhibitors in syndrome of inappropriate antidiuresis be predicted by copeptin, natriuretic peptides and inflammatory markers?

Rianne Nobbenhuis, Julie Refardt, Deborah Vogt

|Feb 06, 2020
A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis.

Julie Refardt, Cornelia Imber, Clara O Sailer

Pageof 2

Frequent Collaborators

4 joint publications

Julie Refardt

3 joint publications

Clara O Sailer

3 joint publications

Mirjam Christ-Crain

1 joint publications

Raban V Jeger